febrile neutropenia

Neutropenic prophylaxis

  • antiviral: acyclovir if HSV+
  • antifungal
    • fluconazole if on cytarabine/venetoclax
    • posaconazole if on 7+3, cytarabine/daunorubicin/midaustaurin
  • antibacterial
    • moxifloxacin inpatient
    • levofloxacin ambulatory

  • maintain gram negative coverage until ANC resolves

Febrile neutropenia is generally defined as a temperature >38.3 C (>101 F) and an absolute neutrophil count <500/mm3.  Most cases are due to gram-positive pathogens such as Staphylococcus epidermidis (most common), Staphylococcus aureus, and streptococci, but gram-negative bacteria (eg, Pseudomonas) are isolated in approximately 25% of cases and are often associated with more severe illness.

Monotherapy with an anti-pseudomonal beta-lactam (eg, piperacillin-tazobactam, cefepime) or a carbapenem is considered first-line treatment in the inpatient setting.  Studies have shown no improvement in mortality with the routine addition of a second agent (eg, vancomycin) targeting gram-positive pathogens.  Indications for vancomycin include:

  • Hemodynamic instability
  • Severe sepsis
  • Pneumonia
  • Positive blood cultures for a gram-positive organism (prior to speciation results)
  • Suspected catheter-related infection (eg, chills during infusion, cellulitis around entry site)
  • Skin or soft-tissue infection